19 Presidential Way
Woburn, MA 01801
United States
(617) 583-1700
https://www.yield10bio.com
Sector(es): Basic Materials
Industria: Agricultural Inputs
Empleados a tiempo completo: 29
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Dr. Oliver P. Peoples Ph.D. | Co-Founder, President, CEO & Director | 358.39k | N/D | 1958 |
Dr. Kristi D. Snell Ph.D. | VP of Research & Chief Science Officer | 287.14k | N/D | 1968 |
Ms. Lynne H. Brum | VP of Planning & Corporate Communications and Secretary | 287.14k | N/D | 1964 |
Mr. Charles B. Haaser | VP of Finance, Chief Accounting Officer & Treasurer | 236.41k | N/D | 1956 |
Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.
La calificación ISS Governance QuickScore de Yield10 Bioscience, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.